Provention Bio, Inc. SEC Filings

Filed On	Filing
08 May 2023	15-12G
28 Apr 2023	EFFECT
28 Apr 2023	EFFECT
28 Apr 2023	EFFECT
28 Apr 2023	SC 13G/A
28 Apr 2023	Form 4: Sessa Capital (Master), L.p., 10% owner and 4 others Disposed of 15,567,497 shares (Tender Offer)
27 Apr 2023	Form 4: Wysenski Nancy, Director Disposed of 207,181 Option to Purchase Common Stock (Disposition to Issuer)
27 Apr 2023	Form 4: Pisano Wayne, Director Disposed of 7,500 shares (Tender Offer) · Disposed of 231,181 Option to Purchase Common Stock (Disposition to Issuer)
27 Apr 2023	Form 4: Palmer Ashleigh, Director and CEO Disposed of 2,570,050 shares (Tender Offer) · Disposed of 2,178,970 Option to Purchase Common Stock (Disposition to Issuer)
27 Apr 2023	Form 4: Jenkins John Kenneth, Director Disposed of 184,981 Option to Purchase Common Stock (Disposition to Issuer)
27 Apr 2023	Form 4: Jain Rita, Director Disposed of 66,000 Option to Purchase Common Stock (Disposition to Issuer)
27 Apr 2023	Form 4: Catlin Avery W, Director Disposed of 20,000 shares (Tender Offer) · Disposed of 231,181 Option to Purchase Common Stock (Disposition to Issuer)
27 Apr 2023	Form 4: Yi Miyoko Christina, Chief Operations Officer Disposed of 537,000 Option to Purchase Common Stock (Disposition to Issuer)
27 Apr 2023	Form 4: Vogel Justin, Chief Accounting Officer Disposed of 413,185 Option to Purchase Common Stock (Disposition to Issuer)
27 Apr 2023	Form 4: Ramos Eleanor, Chief Medical Officer Disposed of 70,000 shares (Tender Offer) · Disposed of 1,492,712 Option to Purchase Common Stock (Disposition to Issuer)
27 Apr 2023	Form 4: Leon Francisco, Chief Scientific Officer Disposed of 2,573,000 shares (Tender Offer) · Disposed of 1,274,353 Option to Purchase Common Stock (Disposition to Issuer)
27 Apr 2023	Form 4: Osorio Benedict, Chief Quality Officer Disposed of 437,000 Option to Purchase Common Stock (Disposition to Issuer)
27 Apr 2023	Form 4: Hoitt Jason, Chief Commercial Officer Disposed of 1,022,250 Option to Purchase Common Stock (Disposition to Issuer)
27 Apr 2023	Form 4: King-Jones Heidy, Chief Legal Officer Disposed of 784,500 Option to Purchase Common Stock (Disposition to Issuer)
27 Apr 2023	Form 4: Chauche Thierry, Chief Financial Officer Disposed of 625,000 Option to Purchase Common Stock (Disposition to Issuer)

Comments